Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Raising Awareness of Acute Kidney Injury: Unfolding the Truth

ACTA MEDICA INDONESIANA · Vol. 54 No. 4 (2023)

ISSN
2338-2732, 0125-9326
Terbit
2023-01-10
Penerbit
The Indonesian Society of Internal Medicine
Bahasa
eng

Abstrak

AKI is rarely being recognized as it may take place without any apparent symptoms. Severe AKI is commonly found in intensive care unit (ICU) patients. AKI in the ICU is an independent risk factor for death, as it may cause systemic effects on other vital organs including the lung, heart, liver, brain and immune system. Some studies have reported that AKI increases susceptibility to infection, doubles the rate of respiratory failure and impairs cardiac function. Considering the substantial impacts of AKI in ICU patients, early implementation of preventive measures should be an essential program which consists of developing AKI risk stratification in the ICU and encouraging the use of novel AKI biomarkers (TIMP-2, IGFBP-7, Cystatin C, IL-18, KIM-1 and NGAL) as well as other risk stratification tools (clinical risk prediction scores, computer algorithms, furosemide stress test). Furthermore, after ICU patients have recovered, AKI survivors are more likely to develop chronic kidney disease (CKD) and end-stage kidney disease (ESKD), imposing significant morbidity in the future. Recent study has shown that nephrologist intervention was associated with lower risk of starting KRT and progression of AKI. The coronavirus disease 2019 (COVID-19) pandemic has caused more than 800,000 deaths worldwide. Kidney involvement in patients with COVID-19 may present as proteinuria or hematuria and may lead to acute kidney injury (AKI). Some initial reports showed that the incidence of AKI in COVID cases was negligible. However, later reports suggested that AKI is actually prevalent in patients with COVID-19, particularly in ICU patients. AKI is now considered as a common complication of COVID-19 and it is also associated with adverse outcomes, including development or worsening of comorbidities, yet little is known about the pathogenesis or optimal management of COVID-19-associated AKI.

Kata kunci

Jaringan kolaborasi para penulis

36 penulis · 152 tautan kepenulisan bersama · 1 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Indraprasta PGRI
  • Institut Agama Islam Negeri Bone
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Kuntjoro HarimurtiAfiliasi tidak diketahui3
Siti SetiatiAfiliasi tidak diketahui2
Idrus AlwiUniversitas Indraprasta PGRI2
Pringgodigdo NugrohoAfiliasi tidak diketahui2
Riadi WirawanAfiliasi tidak diketahui1
Ailinda Theodora TedjaAfiliasi tidak diketahui1
Fify HenrikaAfiliasi tidak diketahui1
Esthika DewiastyAfiliasi tidak diketahui1
Aulia RizkaAfiliasi tidak diketahui1
Dharmeizar DharmeizarAfiliasi tidak diketahui1
Mita Hafsah SaraswatiAfiliasi tidak diketahui1
Meilania SaraswatiAfiliasi tidak diketahui1
Muhammad YaminInstitut Agama Islam Negeri Bone1
Suzanna ImmanuelAfiliasi tidak diketahui1
Eka GinanjarAfiliasi tidak diketahui1
Taufik IndrajayaAfiliasi tidak diketahui1
Arif MansjoerAfiliasi tidak diketahui1
Rudyanto SedonoAfiliasi tidak diketahui1
Ruth V RebeccaAfiliasi tidak diketahui1
Suhardjono SuhardjonoAfiliasi tidak diketahui1
Dimas PriantonoAfiliasi tidak diketahui1
Sally Aman NasutionAfiliasi tidak diketahui1
Ketut SuastikaAfiliasi tidak diketahui1
Pranawa MartosuwignjoAfiliasi tidak diketahui1
Roy Panusunan SibaraniAfiliasi tidak diketahui1
Soebagijo Adi SulistijoAfiliasi tidak diketahui1
Zulkhair AliAfiliasi tidak diketahui1
Birry KarimAfiliasi tidak diketahui1
Erwin SukandiAfiliasi tidak diketahui1
Haerani Abdul RasyidAfiliasi tidak diketahui1
PranawaAfiliasi tidak diketahui1
Nyoman Paramita AyuAfiliasi tidak diketahui1
Siti Elkana NauliAfiliasi tidak diketahui1
Hary Sakti MuliawanAfiliasi tidak diketahui1
Edrian ZulkarnainAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Raising Awareness of Acute Kidney Injury:  Unfolding the Truth</dc:title>
	<dc:creator>Lydia, Aida</dc:creator>
	<dc:subject xml:lang="en-US">acute kidney injury</dc:subject>
	<dc:subject xml:lang="en-US">nephrology</dc:subject>
	<dc:subject xml:lang="en-US">COVID-19</dc:subject>
	<dc:subject xml:lang="en-US">diagnosis</dc:subject>
	<dc:description xml:lang="en-US">AKI is rarely being recognized as it may take place without any apparent symptoms. Severe AKI is commonly found in intensive care unit (ICU) patients. AKI in the ICU is an independent risk factor for death, as it may cause systemic effects on other vital organs including the lung, heart, liver, brain and immune system. Some studies have reported that AKI increases susceptibility to infection, doubles the rate of respiratory failure and impairs cardiac function. Considering the substantial impacts of AKI in ICU patients, early implementation of preventive measures should be an essential program which consists of developing AKI risk stratification in the ICU and encouraging the use of novel AKI biomarkers (TIMP-2, IGFBP-7, Cystatin C, IL-18,  KIM-1 and NGAL) as well as other risk stratification tools (clinical risk prediction scores, computer algorithms, furosemide stress test). Furthermore, after ICU patients have recovered, AKI survivors are more likely to develop chronic kidney disease (CKD) and end-stage kidney disease (ESKD), imposing significant morbidity in the future. Recent study has shown that nephrologist intervention was associated with lower risk of starting KRT and progression of AKI.     The coronavirus disease 2019 (COVID-19) pandemic has caused more than 800,000 deaths worldwide. Kidney involvement in patients with COVID-19 may present as proteinuria or hematuria and may lead to acute kidney injury (AKI). Some initial reports showed that the incidence of AKI in COVID cases was negligible. However, later reports suggested that AKI is actually prevalent in patients with COVID-19, particularly in ICU patients. AKI is now considered as a common complication of COVID-19 and it is also associated with adverse outcomes, including development or worsening of comorbidities, yet little is known about the pathogenesis or optimal management of COVID-19-associated AKI.</dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2023-01-10</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/2350</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 54 No. 4 (2022): Acta Medica Indonesiana; 513</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/2350/618</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Aida Lydia</dc:rights>
</oai_dc:dc>